Literature DB >> 36271980

Downregulatory effect of miR-342-3p on epileptogenesis in the PTZ-kindling model.

Mukaddes Pala1, Ismail Meral2, Nilgun Pala Acikgoz3, Senay Gorucu Yilmaz4, Semra Karaca Okur5, Seyma Acar6, Yalcin Polat7, Fahri Akbas8.   

Abstract

BACKGROUND: Epileptogenesis is a process that results in neurons firing abnormally, causing seizures. Increasing evidence has shown that miRNAs expressed in the epileptic hippocampus are involved in epileptogenesis. We demonstrated the expression changes of miRNAs that may be effective in epileptogenesis in silico analysis in the kindling model created with Pentylenetetrazole (PTZ). Thus, we aimed to identify the target genes responsible for epileptogenesis. METHODS AND
RESULTS: Fifteen male Wistar-albino rats (200-230 g) were randomly divided into two groups control (n = 6) and PTZ (n = 9). The control group received 0.5 ml saline, and the PTZ group (35 mg/kg i.p.) intraperitoneally (i.p.) (11 times, every other day) to induce tonic-clonic seizures. Seizures were observed and scored 30 min after PTZ injection. After the last dose of PTZ (75 mg/kg) administration, the hippocampus tissues of the rats were removed by anesthesia. Analysis of miRNAs was performed with the Affymetrix gene chip miRNA sequence (728 miRNA) and confirmed by the Real-Time Polymerase Chain Reaction (Real-Time PCR) method (29 miRNAs). We evaluated the expression change of the target gene of miRNA, whose expression change was detected using in silico analysis, by q-RT PCR. Eight miRNAs with changes in expression were detected. Of these miRNAs, miR-342-p was downregulated in the PTZ group and was statistically significant (p < 0.005). Ultimately, we determined that the target gene of miR-342-p is a metabotropic glutamate receptor 2 (GRM2) and that GRM2 expression is upregulated.
CONCLUSIONS: Downregulation of miR-342-3p in the PTZ kindling model may result in the upregulation of GRM2.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Epileptogenesis; GRM2 gene; Hippocampus; Pentylenetetrazole kindling model; miR-342-3p

Year:  2022        PMID: 36271980     DOI: 10.1007/s11033-022-08017-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  33 in total

Review 1.  Seizures and epilepsy: an overview for neuroscientists.

Authors:  Carl E Stafstrom; Lionel Carmant
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 2.  The Epidemiology of Epilepsy.

Authors:  Ettore Beghi
Journal:  Neuroepidemiology       Date:  2019-12-18       Impact factor: 3.282

3.  MicroRNAs and target genes in epileptogenesis.

Authors:  Yanyan Feng; Haojun Yang; Yinyan Yue; Fafa Tian
Journal:  Epilepsia       Date:  2020-09-18       Impact factor: 5.864

Review 4.  Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy.

Authors:  Annamaria Vezzani; Silvia Balosso; Teresa Ravizza
Journal:  Nat Rev Neurol       Date:  2019-07-01       Impact factor: 42.937

Review 5.  The neurobiology of epilepsy.

Authors:  Helen E Scharfman
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

6.  A model for focal seizure onset, propagation, evolution, and progression.

Authors:  Jyun-You Liou; Elliot H Smith; Lisa M Bateman; Samuel L Bruce; Guy M McKhann; Robert R Goodman; Ronald G Emerson; Catherine A Schevon; L F Abbott
Journal:  Elife       Date:  2020-03-23       Impact factor: 8.140

7.  Activation of group 2 metabotropic glutamate receptors reduces behavioral and electrographic correlates of pilocarpine induced status epilepticus.

Authors:  Erin H Caulder; Melissa A Riegle; Dwayne W Godwin
Journal:  Epilepsy Res       Date:  2013-11-16       Impact factor: 3.045

8.  Epileptogenicity of brain structures in human temporal lobe epilepsy: a quantified study from intracerebral EEG.

Authors:  Fabrice Bartolomei; Patrick Chauvel; Fabrice Wendling
Journal:  Brain       Date:  2008-06-13       Impact factor: 13.501

Review 9.  Neurodegenerative pathways as targets for acquired epilepsy therapy development.

Authors:  Pablo M Casillas-Espinosa; Idrish Ali; Terence J O'Brien
Journal:  Epilepsia Open       Date:  2020-03-12

Review 10.  Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases.

Authors:  Adam Armada-Moreira; Joana I Gomes; Carolina Campos Pina; Oksana K Savchak; Joana Gonçalves-Ribeiro; Nádia Rei; Sara Pinto; Tatiana P Morais; Robertta Silva Martins; Filipa F Ribeiro; Ana M Sebastião; Vincenzo Crunelli; Sandra H Vaz
Journal:  Front Cell Neurosci       Date:  2020-04-24       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.